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ABSTRACT: The focus of this study was to develop a chemical reaction sequence toward a key benzoxazole building block,
required for clinical manufacturing of a lead candidate in the respiratory disease area. The chemistry consisted of initial low-
temperature reactions with an organometallic reagent to generate the benzoxazole core, and was followed by noncryogenic
transformations toward a sulfonamide substituent. With particular interest in continuous-ﬂow manufacturing we attempted to
integrate the entire sequence on lab scale. Subsequent in-depth process research, supported by PAT and calorimetry studies,
revealed the critical parameters of each step, leading to a more rational attribution of mode of operation: ﬂow, batch, or
semibatch. Two bench-scale cascades of continuously stirred tank reactors (CSTRs) were constructed to meet the challenge of
high exothermicity and solids formation and were key to smoothly upscaling the chemistry to deliver 17 kg of benzoxazole in
superior yield, quality, and robustness.
■ INTRODUCTION
Continuous manufacturing will increasingly be applied where
there is both an interest in extending the palette of permissible
reaction conditions and enabling reaction outcomes which are
highly challenging with the incumbent batch technology.1 An
opportunity in the emerging ﬁeld of continuous manufacturing
is the ability to match-make the ideal reactor to the chemistry in
hand. In an established batch pilot plant the opposite is more
often the case, with the accompanying compromises in
eﬃciency when quality-critical attributes and reactor capabilities
do not align. Considering the smaller reactor volume and lower
capital cost of continuous plants, a tailored approach can be
implemented, whereby the parameters identiﬁed as critical by
detailed process development can be addressed by a subsequent
bespoke reactor design and construction phase. In addition, the
detailed knowledge gained in the laboratory development phase
can be used to appropriately allocate ﬂow or batch techniques
to the sequence of operations, from chemistry, to workup, to
puriﬁcation.2 In this way a line is drawn between ﬂow,
semibatch, and batch methods based on real process require-
ments and not on a desire to implement sequences in ﬂow for
their own sake.
Organometallic chemistry is a tremendous opportunity for
continuous manufacturing3 and has been applied to demon-
strated eﬀect in the industrial arena.4 We have previously
outlined a general methodology enabled by continuous ﬂow
processing toward substituted benzoxazoles starting from 3-
halo-N-acyl anilines.5 The transformation proceeded via base-
mediated deprotonation, ortho-lithiation, and intramolecular
cyclization to provide unstable lithiated benzoxazoles which
were subsequently trapped by a range of electrophiles, Scheme
1. Eﬃcient heat removal, mixing, and avoiding holding-times
were identiﬁed as critical parameters and were the under-
pinning for operating in tubular reactors with precooling loops
at subambient temperatures in continuous ﬂow.
Within our pipeline of projects in chemical development we
identiﬁed a strong overlap with this methodology which could
be used to increase the yield of a key benzoxazole building
block. An active CXCR2 program in the chronic obstructive
pulmonary disorder (COPD) disease area had undergone a
synthesis evaluation phase, identifying optimal routes to the
target squaramide receptor antagonist, Scheme 2.6 All selected
routes required the benzoxazole 1 as starting material, and cost
evaluation highlighted this compound as the key contributor to
the ﬁnal cost-of-goods of the drug substance. In addition the
supply chain for 1 was not robust, with an external contract
manufacturing organization failing to meet the delivery request.
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Scheme 1. Previously Communicated Continuous-Flow-
Enabled Synthesis of Substituted Benzoxazoles from 3-Halo-
N-acyl Anilines
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We therefore initiated the process research and development
toward compound 1 and herein outline the transition from
batch to ﬂow, where appropriate, to achieve a more robust
process with increased yield.
■ RESULTS AND DISCUSSION
Benzoxazole 1 is prepared from N-pivaloyl-protected 3,4-
dichloro aniline 6 according to the chemical sequence
summarized in Scheme 3.7 Under controlled conditions, the
addition of 2 equiv of n-butyl lithium to aniline 6 leads to both
deprotonation of the pivaloyl-amide (6a) and regioselective
ortho-lithiation of the aromatic ring (6b). The ortho-lithiated
intermediate is highly unstable and eliminates lithium chloride
to create a transient aryne (6c) which is immediately quenched
intramolecularly by the nucleophilic tautomer of the lithiated
pivaloyl-amide to provide compound 7.8 Compound 7 is highly
nucleophilic, and timely trapping with sulfur dioxide delivers
the lithium sulﬁnate 8 which has suﬃcient stability to be
isolated and characterized. The standard synthetic sequence to
compound 1 continues however with a dual oxidation/
chlorination with sulfuryl chloride to provide the sulfonyl
chloride 9. Compound 9 was shipped as a stable intermediate
during early manufacturing campaigns, but since identiﬁcation
as a compound with genotoxicity potential is further trans-
formed in the same reactor to the sulfonamide-substituted
benzoxazole 1 by nucleophilic substitution with Weinreb’s
amine, N,O-dimethylhydroxylamine. In batch mode the internal
temperature of the reactor for this one-pot sequence would be
initially set to −30 °C, and a strong scale dependency was
observed with accumulated side products needing purging by
crystallization of 1. On a 30 g scale, an overall yield of 34%
could be achieved in traditional batch mode.
First-Generation Continuous Process, Lab Scale. An
initial lab-scale ﬂow synthesis was devised in order to not only
safely gain process familiarization with limited volumes but also
determine if business beneﬁts such as economy, yield, and
safety could result from a straightforward continuous operation.
As with our previous studies on model benzoxazoles, we
selected tubular reactors and Teﬂon T-pieces in order to
proceed with minimal complication and encounter the
challenges as they presented themselves. A streamlined
transition into continuous ﬂow also enabled us to screen
conditions “on-the-ﬂy” which provided data much more rapidly
than sequential batch reactions under cryogenic conditions ever
could. As the chemistry proceeds stepwise through the
sequence outlined in Scheme 3 the nature of the steps changes
from fast highly exothermic reactions to compound 8 toward
slower, less energetic functional group transformations to
compound 1. As such we chose to break the sequence down
into three parts for our lab-scale studies: (i) cryogenic n-butyl
lithium chemistry; (ii) suﬂur dioxide quench followed by
oxidation/chlorination to the sulfonyl chloride 9; and (iii)
sulfonamide formation. We used our small-scale in-house
automated ﬂow reactor units for these studies, which we term
the exploratory development units (ED-units).9 This allowed us
to both program and track ﬂow rates provided by dual-barrel
continuous syringe pumps, as well as set safety limits for
acceptable temperature and pressure ﬂuctuations. Reactors
were loops of perﬂuoroalkoxy (PFA) tubing, and mixers were
PTFE T-pieces. These units have been used for screening and
early phase clinical supplies for numerous years, and the degree
of mixing in T-pieces has been well characterized.10 Although
scale-up phenomenon will always apply, the ED-units permit a
straightforward transition to our larger scale units, termed
process development units (PD-units), which have an identical
control system, but include pumps capable of higher
throughput.
Scheme 2. Retrosynthesis of the CXCR2 Receptor
Antagonist Identiﬁed Benzoxazole 1 as the Major Cost
Contributor
Scheme 3. One-Pot Synthesis of Benzoxazole 1 from N-Pivaloyl 3,4-Dichloro Aniline 6
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In order to study the ﬁrst step with n-butyl lithium
independently of the subsequent two steps, we selected acetic
acid as an electrophile and targetted the stable proton-quench
compound 10, Scheme 4. Precooling loops ensured that the set
point of −20 °C could be attained in the streams prior to
mixing in T-pieces. Following a screening to determine the
optimum stoichiometry (2.4 equiv of nBuLi) and residence
times (4.5 and 0.4 min respectively), the product 10 was
obtained in 95% isolated yield and 99% selectivity.
With a reliable small-scale procedure for accessing lithiated
intermediate 7 in hand, we switched the in-line electrophilic
quench to a sulfur dioxide solution in THF, setting the
temperature by experiment for this step to 0 °C. Semibatch
quench of this combined stream was made into a solution of
sulfuryl chloride in hexane at 5 °C to deliver sulfonyl chloride
derivative 9 (general approach shown in Scheme 5). However,
the partial insolubility of the sulﬁnate salt 8 formed after mixing
with sulfur dioxide led to clogging of the PFA tubing, and so we
resorted to ultrasound to disrupt the solid accumulation and
keep the reaction medium ﬂowing.11 This proved suﬃcient for
a demo-run, successfully converting 30 g of starting material to
compound 9. The ﬁrst reactions with n-butyl lithium were
considered a priori to be instantaneous, and so we were drawn
to explore more eﬃcient mixing in case this could streamline
our process within the same ED-unit. A number of commercial
micromixers were screened, but those with ﬁne channels led to
plugging. Staying within our remit of developing a lab-scale
demonstration of the capabilities of ﬂow processing, we found a
pragmatic solution with a split-and-recombine reactor consist-
ing simply of a T-piece to divide the stream immediately after
n-butyl lithium addition and a T-piece to reunite the streams
prior to an 11 mL residence volume coil (ﬁnal conditions
shown in Scheme 5). This eﬀort brought the required residence
time for the n-butyl lithium step down from 4.5 to 1.9 min
allowing us to process a further 20 g of compound 6 over 4 h.
This experiment conﬁrmed that we had been, and most likely
still were, highly mixing limited, but since scale-up of this
laboratory setup was not our aim, we pushed forward to
identify upcoming hurdles.
The ﬁnal chemical step in the sequence to benzoxazole 1 was
the conversion of the sulfonyl chloride 9 to the sulfonamide 1
by substitution with Weinreb’s amine. The crude sulfonyl
chloride 9 coming from the ﬂow synthesis contained signiﬁcant
amounts of both residual sulfur dioxide and sulfuryl chloride. In
Scheme 4. Lab-Scale Continuous-Flow Setup for Studying the First Step with n-Butyl Lithiuma
aProtic quench was provided by acetic acid.
Scheme 5. Lab-Scale Continuous-Flow Setup for Studying the Second Step with Sulfur Dioxide and Sulfuryl Chloride
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addition, and for reasons of convenience and safety,12 the
Weinreb amine was purchased as a hydrochloric acid salt and
therefore required deprotonation prior to reaction with 6. In
order to limit the exothermy and avoid salt precipitation, we
therefore opted for partial batch distillation of the reaction
mixture to deplete the gaseous acidic components. The soluble
reaction mixture could then be taken forward and combined
with a basic aqueous solution of the Weinreb amine. Suitable
bases were screened which were considered capable of
deprotonating the amine (pKa 4.8) but hydrolyzing the sulfonyl
chloride 9 to the sulfonic acid at only trace levels, ﬁnally settling
upon dipotassium hydrogen phosphate.13 Screening of reaction
residence time and temperature was conducted in the ﬂow unit,
with use of a glass chicane mixer chip from Little Things
Factory14 providing superior mixing of the organic and aqueous
streams compared to an empty tube, Scheme 6. Operating at 80
°C the reaction required 25 min to reach full conversion,
although this reaction time varied upward with increasing
amounts of residual sulfur dioxide and sulfuryl chloride in the
crude starting material stream.
Since the projected maximal commercial volume of the drug
candidate was signiﬁcantly less than 100 ton/annum, we
decided that the workup and crystallization of compound 1
could be suﬃciently addressed by batch operations. The
product stream containing crude compound 1 was combined
with toluene and aqueous citric acid. Upon mixing and
separation of the phases the organic phase was extracted once
more with sodium bicarbonate prior to a complete distillative
solvent-switch to toluene down to a desired concentration. n-
Heptane was added to the heated solution at 50 °C, and a
cooling ramp brought about the crystallization. After washing
the ﬁlter cake with toluene/heptane and subsequently drying,
benzoxazole 1 was delivered as oﬀ-white crystals.
Having identiﬁed optimal conditions for a lab-scale synthesis
of benzoxazole 1 in three continuous-parts, we proceeded to
combine these operations into one continuous processing line.
The resulting assembly is pictured in Figure 1 and contained
three thermostated baths (one sonicated) and ﬁve pumps (four
syringe-pumps and one Knaur pump). Since the sulfonamide
formation is at the tail-end of the chemical sequence, and has in
any case the slowest kinetics of the tranformations, a 200 mL
wide-bore (1/4″) PFA tube was used to enable complete
conversion, with insertion of static mixer elements to ensure
suﬃcient mixing eﬃciency, plug ﬂow and heat-transfer. The
schematic of this three-step lab-scale unit is outlined in Scheme
7.
Unfortunately clogging of the lines in various positions
plagued this ambitious attempt. Both switching of the narrow
bore 1/16″ PFA tubing for larger 1/8″ tubing and dilution of
the starting material steam (0.45 M) were of little eﬀect, and
the samples that could be taken showed mediocre conversion
(60%). The lab-scale eﬀort was put aside with the conclusion
that sonication had proved unable to manage the solid
generation in the PFA tubing. The batch partial distillation of
the crude sulfonyl chloride solution of 9 to reduce gaseous
acidic components had been left out of this fully continuous
setup, and this shortcut had evidentally led to an excessive
precipitation of the ammonium salts of the Weinreb amine.
Although falling-ﬁlm distillation could have been implemented
in-line prior to the combination with Weinreb amine, this was
outside the scope of this lab-scale study. Preferable was to take
stock of the advantages discovered so far and then segregate
batch and ﬂow processes based on a more in-depth analysis of
the sequence.
Notable was that the ﬁrst two reactions to compound 8 had
delivered a 94% in situ yield, compared to 57% in batch when
operating in disconnected fashion in continuous ﬂow. The third
step, the amidation, step showed great potential with 95% yield
in ﬂow to crude compound 1. Since we already envisaged that
recrystallization of compound 1 was to be kept as a batch
process, we knew from experience that an 80% yield for this
puriﬁcation step could be expected, giving an overall estimated
yield of 70% for the ﬂow-enabled process. Compared to the
34% overall yield of the purely batch process, the ﬂow approach
had clear potential, but only if the issues of solid-generation
could be appropriately addressed. Having provided a suﬃcient
Scheme 6. Lab-Scale Continuous-Flow Setup for Studying
the Third and Final Step with Weinreb Amine To Provide
Benzoxazole 1 with Sulfonamide Substitution
Figure 1. Lab-scale continuous-ﬂow unit for preparing benzoxazole 1
in three chemical steps from N-pivaloyl 3,4-dichloro aniline 6.
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lab-scale proof-of-concept, and with the opportunity of
supporting a 15 kg clinical phase I delivery in view, the team
initiated an in-depth study of the chemistry.
In-Depth Process Development for a Second-Gen-
eration Mini-Pilot Process. In order to attribute the
appropriate reactor to each chemical step we began by
evaluating the heat-release proﬁle of the sequence with reaction
calorimetry in batch. The entire chemical sequence was run in
an RC1 calorimeter in order to accurately measure the heat
ﬂow during each rapid dosing step, Figure 2.
As expected, with the serial dilution that occurs on stepwise
addition of each reagent, the adiabatic temperature rise of each
consecutive step decreases. Of particular note however is the
very high adiabatic temperature rise of 110 °C following the n-
butyl lithium addition. During this experiment the concen-
tration proﬁle of each intermediate was followed by online FT-
IR analysis of characteristic signals, Figure 3. A complete
overview of the trending concentrations could be obtained,
which was particularly pleasing since few, if any, of these
intermediates were expected to be stable enough to be obtained
as isolated analytical references.
In order to render the data acquired by FT-IR quantitative,
oﬀ-line 1H NMR was also used to track key intermediates and
byproducts. Once the mol % at a particular time point could be
determined by NMR with an internal standard, the peak height
by FT-IR could be correlated to this concentration at the same
time point. In this way the continuous data stream coming from
the noninvasive FT-IR could be used to build a kinetic model of
the reaction progress at a variety of temperatures and
concentrations. Particularly insightful was the plot shown in
Figure 4 which depicts the dose-controlled transition from
compound 6 to compound 7. We determined that, at the slow
dosing rate of n-butyl lithium in this experiment, both reactions
were addition-controlled, but the rate of conversion of 6 into 6a
had to be much faster than that for 6a to 7 in order to account
for the sharp transitions observed in the concentration proﬁles
of 6a and 7. As such the ﬁrst equivalent of n-butyl lithium was
almost entirely being employed in deprotonation of 6 to 6a,
with very little being made available for ring closure of 6a to 7
(via ortho-lithiation and aryne formation).
In order to explore deviation scenarios we devised an NMR
experiment where dosing of n-butyl lithium was signiﬁcantly
faster and a local hot spot was certain to exist. At a faster dosing
rate we reasoned that we might shift away from a purely dose-
controlled addition and begin to accumulate n-butyl lithium
which could then be employed for not only selective
deprotonation of 6 to 6a but also a parallel ring closure from
6a to 7. This would put lithiated benzoxazole 7 in the presence
of starting material 6, a situation that we expected to
compromise the selectivity of the reaction due to proton
transfer between the acidic 6 and basic 7.15 The half a mount of
n-butyl lithium (1.05 instead of 2.10 equiv) was added quickly
to the starting material at −35 °C and a sample quenched with
deuterated methanol at various time points. Figure 5 shows the
1H NMR spectra at 0.5 and 2.5 h where lithiated starting
material 6a, lithiated benzoxazole 7, and other compounds can
be identiﬁed as deuterium-quenched species (compound 6
could not be tracked by NMR due to background deuterium
exchange of the acid NH proton). At 0.5 h (Figure 5a)
compound 6a was the predominant product as expected, but
already present was 10% of compound 7 which had evidently
formed in parallel due to non-dose-controlled conditions
Scheme 7. Lab-Scale Continuous-Flow Schematic for Preparing Benzoxazole 1 in Three Chemical Steps from N-Pivaloyl 3,4-
Dichloro Aniline 6
Figure 2. Heat-release proﬁles during an RC1 calorimetry study. Heat
of reaction was determined from the area under the curves and is
reported in kJ/mol of N-pivaloyl 3,4-dichloro aniline 6. Calculated
adiabatic temperature rise is reported in brackets.
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brought about by accumulation of n-butyl lithium. Since a 9:1
ratio of 6a to 7 was integrated, by subtraction this required that
residual starting material 6 was still present in an approximately
5% amount to account for the 1.05 equiv of n-butyl lithium
initially added (otherwise a ratio of 10.0:0.5 of 6a to 7 would
have been observed if all 6 had been consumed). By 2.5 h,
Figure 5b, the newly identiﬁed proton-quench byproduct 10
had appeared in a 1:1 ratio with cyclized compound 7, as would
be expected by the complete proton transfer from residual
starting material 6 (initially 5%) to compound 7 (reduced now
from 10 to 5%), with Figure 5c showing reference spectra of the
proton-quenched byproduct 10 prepared separately. Based on
this NMR study we concluded that if the chemistry was
conducted under conditions where there was coexistence of
compounds 6 and 7 we would always generate byproduct 10 by
proton transfer if suﬃcient time was given.16 In this way we
determined that a slow dosing rate would be a critical
parameter if we wanted to avoid a local-zone eﬀect, i.e. an
accumulation of n-butyl lithium in the dosage area in batch.
This was certainly a compatible criterion for the batch
equipment which would otherwise reliably generate a hot
spot in the dosage area based on the calorimetry data outlined
above.
Regarding the stability of compound 7, similar NMR
experiments with a slower dosing of 2.1 equiv of n-butyl
lithium (i.e., seeking to eliminate the possible presence of
residual starting material 6 in the presence of lithiated 7, even
during the dosing period) demonstrated that at −15 °C the
lithiated intermediate 7 could be held for up to 1.5 h without
signiﬁcant degradation. However, if the temperature was raised
to 0 °C then up to 70 mol % of a new byproduct identiﬁed as
dimeric 11 was formed within 1.5 h, Table 1. The data strongly
suggested that dimeric 11 was being formed from desired
intermediate 7 at this temperature.17 In complement, FT-IR
tracking at three temperatures (10, 0, and −10 °C) conﬁrmed
the temperature sensitivity, and the kinetic data were used to
set a maximal internal temperature of −10 °C for the ideal
process.18
In conclusion to these mechanistic studies, we took the NMR
and FT-IR data together and realized that in order to retain the
high purity of lithiated intermedate 7 the ideal process would
require a long n-butyl lithium dosing time and good mixing to
avoid a local-zone eﬀect and the resulting issues of proton
transfer from residual 6, as well as hot spots. However, the
holding time of 7 should be as short as possible to avoid
decomposition in general and dimerization to 11 in particular.
Figure 3. Concentration proﬁles were obtained based upon online FT-IR tracking of characteristic signals.
Figure 4. Concentration proﬁles derived from FT-IR data show the transformation of compound 6 into compound 7 via deprotonated compound
6a.
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Our conclusion was that this paradoxical situation excluded the
possibility of using batch equipment on manufacturing scale,
since a long dosing time would equate to a long holding time of
7 during dosing, and the mixing eﬃciency of large batch
reactors was expected to decrease on increasing volume. In ﬂow
equipment the dosing time is quasi-equivalent to the mixing
time and can be rapid with judicious choice of ﬂow rates and
mixer type. Heat removal can also be excellent due to the
higher surface-area-to-volume ratio compared to batch. Finally,
the holding time of 7 could also be short in continuous ﬂow
since the next reagent would intercept the reaction mixture
after a short time deﬁned by the ﬂow rates and volume of the
selected equipment. The combination of calorimetry, FT-IR,
and NMR studies therefore consistently pointed us toward
carefully designed continuous ﬂow equipment to handle the
ﬁrst step of the sequence toward compound 1.
NMR-based stability experiments on the lithium sulﬁnate 8
resulting from sulfur dioxide quench showed that it was entirely
stable at the low temperature required for the ortho-lithiation.
The ﬁrst signs of decomposition according to SETARAM
calorimetry began at 97 °C. Equally sulfonyl chloride 9 was
found to be stable in the reaction medium, with NMR holding
experiments at room temperature over 3 days showing no sign
of degradation. Background hydrolysis of 9 by the aqueous
solution of the Weinreb amine was to be expected, however,
and screening of the base required to deprotonate the Weinreb
amine salt (vide supra) had already led us to select dipotassium
hydrogen phosphate. Further inorganic carbonate and
phosphate bases were included in the extended screening, but
dipotassium hydrogen phosphate led to the least decom-
position of compound 9 over an extended period at 30 °C
according to quantitative HPLC, Table 2.
Sulfonyl chloride 9 was found to hydrolyze to the sulfonic
acid only at elevated pH. Conversely, low pH led to ring-
opening hydrolysis of the oxazole moiety in compound 1 to
provide a phenolic compound. As such we avoided extreme
acidity or basicity by only dosing 40% of the full 10 equiv of
aqueous dipotassium hydrogen phosphate solution to the
sulfonyl chloride, the remaining 60% coming premixed with the
Weinreb amine in aqueous solution.
Having determined the kinetics for each of the byproduct
pathways, summarized in Figure 6, these pathways were
incorporated into the Dynochem-based kinetic model to enable
an overall simulation of the reaction within the ﬂow reactor
equipment (see the Supporting Information).
In order to eﬀectively select the appropriate ﬂow reactor we
needed to tackle the issue of solid-generation which had been a
critical issue on lab scale. Lithium chloride is a prime suspect as
a precipitant in all chemistries between organolithium reagents
and chloro-aromatics. Commercial solutions of lithium chloride
are available at 0.5 M in tetrahydrofuran, and the maximum
possible concentration in our chemistry was calculated at 0.3 M
Figure 5. Successive NMR experiments at half-dosing of n-butyl lithium demonstrated the proton exchange between compounds 6 and 7 to generate
proton-quench byproduct 10.
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(1.0 equiv). However, since our solution contained dissolved
substrates, and we operated at subambient temperatures, we
initiated a seeding experiment to determine if we were
operating under conditions of supersaturation. Small, but
successive amounts of lithium chloride (0.03 eq. then 0.04
equiv) were spiked into the mixture of starting material 6 and
n-butyl lithium at −30 °C, but gratifyingly no crystallization
event was observed over a 2 h aging period.19
Lithium sulﬁnate intermediate 8 is a known solid, and so as a
next step we prepared it in a separate experiment and
recirculated a concentrated suspension by peristaltic pump
between two glass vessels with a gravity overﬂow between
Table 1. Operating at 0 °C: Tracking of Byproducts Generated during the n-Butyl Lithium Step by 1H NMR after Quench with
Deuterated Methanol
Table 2. Hydrolysis of Sulfonyl Chloride 9 after Mixing with Aqueous Base at 30 °Ca
aDecomposition was measured by HPLC with internal standard (toluene).
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them.20 Over 24 h no accumulation of solids at the bottom of
the vessels or at the overﬂow junction was observed.
A clue in determining the complete source of unwanted
solids was the observation of the alkyl sulfonamide 12 in the 1H
NMR of the crude benzoxazole 1, which was presumed to
derive from the combination of residual n-butyl lithium and
sulfur dioxide, Figure 7. The lithium salt of n-butyl sulﬁnate was
synthesized and isolated and found to be a waxy solid, capable
of sticking to glass surfaces. A useful observation was that it
could be washed oﬀ with fresh tetrahydrofuran. In summary we
would therefore have to design a continuous reactor capable of
handling a solid lithium salt, and we would have to introduce
intermittent cleaning with tetrahydrofuran for the 15 kg clinical
supply campaign.
Reactor Selection and Design. The process development
had revealed that selection of a suitable reactor would have to
be made taking into account multiple requirements: heat
management; avoiding local concentration zone eﬀects;
avoidance of holding times; and resistance to plugging. Three
types of reactors were made on the basis of comparison: a large
semibatch reactor; a tubular reactor (i.e., a pipe); and a cascade
of continually stirred tank reactors (cascade of CSTRs, i.e. a
series of stirred batch reactors with overﬂow junctions), Table
3.
Based on these summaries we made the following selection:
for the ﬁrst two chemical steps in the sequence to the sulﬁnate
8, where exothermy, local-zone eﬀects, holding time, and
plugging were all found to be critical parameters, we selected an
approach using a cascade of CSTRs.21 Not only do cascades
resist plugging if correctly proportioned,22but multipoint
addition of reagent enables the heat of reaction to be spread
across more than one vessel. Mixing eﬃciency at each addition
point would require study, but the NMR experiments suggested
that it needed to be on the order of seconds but not
instantaneous. Equally, residence time distribution would also
require characterization, but our expectation was that a cascade
of CSTRs could be designed to operate on the order of minutes
rather than hours and would therefore be suﬃcient to avoid the
byproducts resulting from extended holding of aryl lithium 7.
We selected a batch reactor for the third and ﬁnal chemical step
Figure 6. Summary of the elucidated byproduct pathways based on chemical stability studies which relied on NMR, FT-IR, and HPLC data.
Figure 7. Identiﬁcation of compound 12 in crude compound 1, which derives from the lithium salt of n-butyl sulﬁnate, found to be a waxy solid
(pictured).
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Table 3. Comparison of Three Ideal Reactors for Synthesis of Benzoxazole 1
Figure 8. Heat proﬁles for the start-up phase of each vessel of the ﬁrst CSTR planned to handle the n-butyl lithium step.
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to benzoxazole 1 where all these factors were no longer critical.
The junction between the two equipment types would be
semibatch with a strategy required to manage the transition
between nonstop ﬂow and sequential batch operations.
With a cascade of CSTRs the choice of number of connected
vessels is a balance between simplicity (less vessels) and
narrower residence-time distribution (more vessels). If
residence-time distribution is too broad, the selectivity of the
Figure 9. Heat proﬁles for the start-up phase of each vessel of the second CSTR planned to handle the sulfur dioxide addition step.
Figure 10. Overall setup of the sequence from compound 6 to benzoxazole 1 is shown as a schematic. Pictured are the prototype cascades of CSTRs
constructed for the n-butyl lithium step (left, in stainless steel, opened) and the sulfur dioxide addition step (right, in glass, closed and ﬁlled with
colored solution).
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reaction can suﬀer by virtue of back-mixing. Using the kinetic
model, so far used to predict byproduct levels, we could also
simulate a variety of vessel numbers for the n-butyl lithium step.
In addition the material of construction was varied in silico, and
the heat proﬁle in each of the ﬁve vessels of the cascade was
predicted. Our aim was to have the cooling medium set to −30
°C23 and ensure that the internal temperature in the vessels
never exceeded −10 °C, a value chosen to avoid formation of
the dimeric compound 11 discovered in our search for
temperature-sensitive byproducts (vide supra). Based on
running a variety of setups we selected a ﬁve vessel cascade
constructed of stainless steel and opted for a two-point dosing
of n-butyl lithium into vessel 1 and vessel 3 (1.1 equiv then 1.3
equiv) in order to limit the maximal hot spot temperature.
Mixing time was calculated to be complete within approx-
imately 4 s, and the required residence time in the entire
cascade of CSTRs was calculated to be 1.4 min (see the
Supporting Information). The outcome of the simulation for
the start-up in this ﬁrst step in the theoretical ﬁve-vessel CSTR
is shown in Figure 8, with vessels 1 and 3 evidently stabilizing
as warmest due to the dosing of n-butyl lithium.
For the second chemical step we preferred a single dosing of
sulfur dioxide and would not be able to use stainless steel due
to the high acidity of the reaction medium due to the nature of
sulfur dioxide. However, borosilicate glass was considered ideal
as reactor material since we needed to be able to visualize the
reactor contents to determine what degree of accumulation of
solids was taking place. Again a ﬁve-vessel CSTR was selected,
and heat proﬁles based on simulation are shown in Figure 9.
The maximal steady-state vessel temperatures were considered
suitable for this reaction step based on the knowledge gained
from the studies into byproduct pathways deriving from
compounds 7 and 8. The required residence time was
calculated to be 1.1 min.
A speciﬁc design for each CSTR vessel was further reﬁned
based on feedback from the simulation software, allowing vessel
dimensions, impeller size, and stirring rate to be selected to
match our requirements. An on-site workshop then built the
prototypes pictured in Figure 10. Of particular mention is the
overhead stirring system that operated by cam-belt.
Since the lithium sulﬁnate 8 and sulfonyl chloride 9 were
found to be suﬃciently stable,24 the decision was taken that the
outlet of the second cascade would mark the boundary between
batch and ﬂow. While sulfonyl chloride was found to be
chemically stable in hexane over multiple days at room
temperature, a phase separation was observed after only a few
hours. This meant that the solution would have to be freshly
prepared at regular intervals, and so the receiver vessel
postioned downstream of the cascades was sized so that it
would need reﬁlling approximately once per hour.25
Finally sulfonyl chloride 9 would be converted to target
benzoxazole 1 by reactive extraction with the hydrochloride salt
of Weinreb’s amine and dipotassium hydrogen phosphate as
outlined above. For the clinical supply campaign these
operations would take place in the existing batch pilot-plant
equipment with a 12 h periodicity, meaning that sulfonyl
chloride 9 would be accumulated every hour into a batch
reactor for half a day prior to conversion to crude compound 1
in one lot. Equally, crystallization of compound 1 from
isoproylacetate and heptane would be made on accumulated
batches of crude compound 1 in order to limit the number of
manufacturing operations requiring pilot-plant personnel.
Pilotation of the Second-Generation Process: Com-
bining Flow and Batch. The process-development unit (PD-
unit) was tasked with pumping and process control, while
adjacent mobile skids were installed for housing the two
cascades of CSTRs and the semibatch quench vessel, Figure 11.
Overﬂow tanks were installed, connected to the highest point
Figure 11. Mini-plant setup for continuous processing of starting material 6 to sulfonyl chloride 9. The PD-unit is on the left-hand side and on the
upper right the two cascades of CSTRs with semibatch quench vessel on the lower right mounted on the mobile skid.
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of each CSTR in the event of clogging, and a perspex box was
placed over the two CSTRs in order to safely inertize this area
to limit ice formation on the outer reactor walls.
Common to our ED- and PD-units, process monitoring and
control would be mediated by HITEC ZANG software, with
safety ranges on pressure, temperature, and ﬂow rate
preprogrammed to trigger an automated pump stop. Residence
times in the ﬁrst and second CSTRs were set to 1.4 and 1.1 min
respectively, and so with a volume of 50 mL each (5 × 10 mL
vessels) the ﬂow rate for the 0.5 M starting material solution 6
was set to 25 mL/min. The ﬂow rates for the other feeds were
assigned accordingly, and a familiarization campaign was
initiated. Four 12 h runs were completed, with interruptions
of the pumps required due to two principle issues, both
occurring on the n-butyl lithium line: irregular ﬂow due to
degassing of the dissolved nitrogen and butane, and inaccurate
ﬂow rate of n-butyl lithium due to suboptimal performance of
the magnetic gear pump. Satisﬁed to have identiﬁed these
technical issues prior to the manufacturing campaign, we
nonetheless proceeded to crystallize the processed crude
benzoxazole 1 in three batches and were able to deliver a
total 4.9 kg of 1 in excellent purity above 99.5 A%. The overall
yield was 65%, notably higher than the benchmark of 34% for
the optimized batch process, and there was clearly space for
technical improvement. An in-line degasser was installed prior
to the pumps, which were themselves replaced with better
suited microannular gear pumps. Now with the pilot-plant
operators experienced in this novel sequence of ﬂow and batch
operations, and the change in equipment, the full manufactur-
ing campaign was initiated. The campaign ran continuously for
72 h, with the cycle time for batch conversion of sulfonyl
chloride 9 to crude 1 set to once every 18 h. The pressure,
temperature, and HPLC proﬁles for the ﬂow part to compound
9 can be seen in Figure 12.
With the more optimal setup the campaign proceeded
smoothly. As can be seen from the pressure proﬁle for pump 1
(starting material, purple line), ﬁve cleaning periods were
manually triggered based on a visual control of the buildup of
solids on the inner surface of the glass CSTR (switch to solvent
visible as sudden pressure drops, as well as temperature drops
(red line) due to a drop in exothermy). When at steady state
the quality of compound 9 was evenly high, averaging at 88%
assay yield, and although the four reactive extractions in batch
delivered yields of crude 1 with some degree of variability (68−
85%), the outcome was well within the predeﬁned quality and
quantity limits, Table 4. The four batches of crude 1 were
combined into two crystallization batches delivering 5.6 and 6.0
kg of benzoxazole 1 in high purity (99.6 and 99.8 A%
respectively). The material prepared according to this process
met all testing requirements and was released ready for use in
clinical manufacturing.26
In summary the campaigns delivered a total of 17 kg of
isolated compound 1, with the second campaign (72 h)
achieving an overall 65% yield. According to raw material
calculations, the near doubling in yield to benzoxazole 1 had a
predictably major eﬀect on the total product cost of the
manufacturing of the CXCR2 receptor antagonist drug
candidate, with conservative calculations delivering a 35%
reduction in costs. More than this, a robust supply of the
building block had been ensured for future manufacturing
supplies.27
■ CONCLUSIONS
In conclusion a demonstration of the potential of continuous
manufacturing had been established on the lab scale for the
entire sequence from anilide 6 to benzoxazole 1. This eﬀort
highlighted the need for a better ability to handle solid
formation, and so a PAT- and calorimetry-supported process
Figure 12. 72 h Continuous manufacturing campaign, proﬁling HPLC assay yield of compound 9 (green triangles), pump ﬂow rates (purple, blue,
and green traces; see legend for details), and temperature in the semibatch reactor (red trace). The chart is divided into the four batches, with assay
yield of compound 9 given according to HPLC.
Table 4. Mass-Flow and Quality Attributes for the 72 h Continuous-Enabled Campaign to Benzoxazole 1
batch
no.
kg of 6 (100%), pumped as
13 mol % THF solution
in situ yield
of 9 (%) purity of 9 (A%)
in situ yield of
crude 1 (%)
kg of 1 by HPLC
assay (mol %)
kg of
isolated 1
Overall
yield to 1 Purity of 1 (A%)
1 3.32 84.0 92.8 67.7 3.04
5.64 62.8 99.6
2 3.32 93.0 91.8 80.6 3.62
3 3.32 85.0 91.7 79.0 3.55
6.02 67.0 99.8
4 3.32 90.0 89.0 85.3 3.83
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development was conducted which revealed the quality critical
attributes for each step in the sequence. The rational allocation
of batch, semibatch, and ﬂow reactors then followed, making
use of kinetic modeling and simulation tools not only to predict
optimal operating conditions for the chemistry but also for the
design of the ﬂow reactors for the low-temperature steps. The
driver for ﬂow was a combination of the need for maintaining
low temperature despite high exothermy, with a strictly minimal
dosing and holding time to avoid byproduct formation.
Cascades of CSTRs were selected with diﬀerent materials of
construction and, despite the need to process solid lithium salts,
served their purpose well in the ensuing campaign in the
bespoke mini-plant which delivered 17 kg of benzoxazole 1
with superior yield and high quality.
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